http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2429840-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b237654743cfc467cfb349019c9b4240 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_557d83b662c66efa7b46058b57f31276 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4375 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-06 |
| filingDate | 2010-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2011-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d340d957385d3aa3181f43a63c07e821 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_51e7c4f419ee9b2c5761804e08d6ceb6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f5bd9ba02fabf533b2f84830cfe6ac5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c42fd194fd4f774549d1a42cc8d74c32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b22febf32cffd7659383b4ebde534ad6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_85a63b247e1817760ce0a0e6dcdac4bf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_da837501de504893d0a60871af1de727 |
| publicationDate | 2011-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2429840-C1 |
| titleOfInvention | Agent preventing mammal normal cell transformation in malignant cells |
| abstract | FIELD: medicine. n SUBSTANCE: group of inventions refers to substances preventing malignant regeneration of mammal (including human) normal cells in malignant cells. Aaptos sp. sponge is used to produce an aaptamine analogue, namely 3-N-morpholinyl-9-demethyloxyaaptamine exhibiting ability to prevent mammal normal cell transformation in malignant cells. What is offered is use of 3-N-morpholinyl-9-demethyloxyaaptamine, and also its analogues 9-demethyloxyaaptamine, isoaaptamine, 3-phenethylamino-9-demethyl oxyaaptamine and 3-isopentyl amino-9-demethyloxyaaptamine as such agent. Besides, these substances are used for preparing pharmaceutical compositions preventing mammal normal cell transformation in malignant cells. 3-N-morpholinyl-9-demethyloxyaaptamine and its analogues have a cancer-preventive effect in the concentration nontoxic for normal cells. n EFFECT: reduced risk of toxic action on body after prolonged administration of the substances. n 3 cl, 1 dwg, 10 tbl, 7 ex |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112500409-A |
| priorityDate | 2010-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 142.